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Abstract: 
Objective: To assess our local status of concentrations hormonal and biochemical in response to combined oral 
contraceptive pill  between women who suffer from delays in the case of pregnancy after stopping use of the oral 
contraceptive pill and control group women's and its relationship to age.Methods: study was included (80) 
married women in Kut city the  ranged age between (20-40) years. who have given birth to at least one child , 
they do not suffer from any medical condition , since the beginning of January until end of August has divided : 
(40) the case of women who suffer from delays in the case of pregnancy after stopping use of the oral 
contraceptive pill .control group women's who did not take their no way to prevent pregnancy included 40 
married divided by age to twenty women each age group.Results: There was a significant (P <0.05) in hormonal 
testes : decrease in the rate of follicles stimulating hormone (FSH) in the women have left the oral contraceptive  
pill and suffer from late pregnancy , a rise in the rate of the hormone progesterone in the women have left the 
oral contraceptive  pill and suffer from late pregnancy compared to control women . Significant increase (P 
<0.05) in the concentration of total cholesterol (T.ch) in women's who suffer from late pregnancy after stopping 
use oral contraceptive pill compared control group women's. non Significant decrease (P >0.05) in the mean 
values of High density lipoproteins (HDL). exist the effect of age in the study of all parameters hormonal and 
biochemical in this study. Prevalence the case of late pregnancy in the women have left the oral contraceptive  
pill in Kut city. 
Keyword: oral contraceptive pill, FSH, Progesterone ,cholesterol ,HDL, Age. 
 
Introduction 
Most women currently use oral contraceptives  pill to prevent pregnancy. The pill is the most widely used 
method of birth control (Mosher and Jones, 2010). Many women not only use birth control pills for family 
planning, but also because the pills can alleviate some symptoms associated with their menstruation cycle such 
as acne, anemia due to heavy menstrual bleeding, and premenstrual dysphoric disorder  (José et al., 
2013).Contraceptive pills is Synthetic hormones derivatives manufactured chemically, and their influence and 
physiological impact of natural hormones secreted by the ovary help prevent pregnancy in spite of continuing 
sexual relationship (Noe  et al., 2011 ; Novikova et al., 2007 ) .   
The basic mechanism by which they operate to prevent the development of the vesicle and thus 
inhibiting ovulation (David et al., 2004 ) it affects the hypothalamus gland through the suppression of secretion 
Gonadotrophine Releasing Hormones (GnRH) (Trussell and James, 2007) and follicle stimulating hormone 
(FSH) and is responsible for the evolution and maturity of Graffinn Follicle and Leutinizing  hormone (LH) 
responsible for the explosion of the vesicle and then the start of the egg  (Ferro and Jamie, 2005). the presence 
of progesterone receptors are less than the estrogen receptors on various tissues of the body ; including brain 
tissue cells leads to two types of nutritional regulation, and potentially the estrogen change neurons secreting 
Neurosecretory cells properties that produce and secrete hormones of the hypothalamus, progesterone hormone, 
synthetic steroids that mimic the actions of endogenous progesterone. The new progesterone definition 
progestins (Su and Lian, 2012) .One of the main actions of progestin is the secretory transformation of an 
estrogen-primed endometrium. Both hormones prevent the over-proliferation of the endometrial tissue. The 
effects of progestins are related to interactions not only with progesterone receptors, but also with other steroid 
hormone receptors: androgen receptors, estrogen receptors, glucocorticoid receptors, or mineral corticoid 
receptors  (Frempong et al., 2008). These interactions may either induce trans activation of a steroid receptor or 
prevent activation. In the target organ, the balance between the receptor coactivators and corepressors recruited 
by a progestin determines whether the overall effect of the molecule will be agonistic or antagonistic (Endrikat 
et al.,  2011). All progestins bind to the progesterone receptor and have the expected effect on the uterine 
endometrium, progesterone has several biological actions. It transforms the endometrium into a secretary tissue 
to permit implantation of a fertilized ovum, In addition, progesterone has an antiandrogenic effect (Skouby et al., 
2005) .Progesterone competitively inhibits the action of androgen, as it is a preferred substrate to the enzyme 5a-
reductase, preventing the conversion of testosterone into its active metabolite dihydrotestosterone . Progesterone 
also interacts with the mineral ocorticoid receptor; competitive binding to this receptor by progesterone prevents 
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its trans activation and inhibits the mineralocorticoid effect (Mohammad et al., 2013). 
 
Experimental design: 
The study included follow-up (80) cases married women, and revisions to the hospital after the confirmation of 
their health and that they do not suffer from any medical condition in Obstetrics , Zahra teaching Hospital and 
Kut Hospital for Women and prerace of Kut, since the beginning of January 2016 until the end of the month of 
August have been divided into two groups : 
Group I: Included follow-up (40) the case of women who suffer from delays in the case of pregnancy 
after dropping the use of the pill ( given birth to at least one child before use of oral contraceptive pill ). The type 
of oral contraceptive pills used Microgynon German origin type, ( (0.03) mg Ethinyl-Estradiol,(0.15)  
Levonorgestrel ). were divided according to their age into sub groups: The first group ranged  between (20-30) 
years,The second group ranged between (31-40) years. 
Group II: A control group included 40 married women who did not use oral contraceptive pills or any 
objection earlier and be of those who have given birth to at least one child too, ages ranged between (20-40) 
years, were divided by age as in the first set by twenty women each age group, has also been making sure their 
fertility through a hormonal and biochemical tests. 
 
Data and blood sample collection 
5 mL venous blood had been taken for each women's conducted the study , the samples were transferred to a 
private pipe free of any anti-clotting substance and left degree lab temperature for a period of 10-15 minutes, 
then renounced mediated Centrifuge speeds of 3000 r / min for the purpose of separating the serum from the rest 
of its components. Serum was separated and put in two tub, the first biochemical tests: Tch, HDL, were 
conducted using Biosystem kits auto analyzer . the second hormonal tests preserved at a temperature of ( 20) - ° 
C:FSH, Progesterone hormones 
FSH: It has been drawing blood in the Follicular phase, particularly in the second day of the Menstrual 
cycle. 
Progesterone hormones : It has been drawing blood in the luteal phase specifically in the days (17-21) 
of the menstrual cycle  
 
Statistical analysis: 
Statistical analysis was performed with SPSS software. Data were analyzed using analysis of paired-samples T-
test for comparison between different group. Results were reported as mean ± S.E. and differences were 
considered as significant when P<0.05. 
 
Results: 
Table (1) shows Hormonal and biochemical of the study population. Results  of the Hormonal testes is The mean 
values of FSH in the follicular phase were reduced significantly Among the women's users group of the oral 
contraceptive pill and left users who suffer from late pregnancy than control women's group not users of the oral 
contraceptive pill never (P<0.05) respectively (2.063 ± 0.134), (7.570 ± 0.521) while progesterone hormone in 
the luteal phase were show high significantly (P<0.05) respectively mean (36.186 ± 1.007) , (17.152 ± 2.065) in 
women's users group of the oral contraceptive pill and left users who suffer from late pregnancy than control  
group not users of the oral contraceptive pill never.  
We found a high significant in Total cholesterol (T.Ch) between women's users group of the oral 
contraceptive pill and left users who suffer from late pregnancy and control women's group not users of the oral 
contraceptive pill never in this study in average (176.192 ± 0.925) , (163.776 ± 1.225) respectively (P<0.05). 
while was reduces no significant in mean High density lipoproteins (HDL) (39.158 ± 0.314) , (39.670 ± 0.602) 
(P>0.05).between women's users group of the oral contraceptive pill and left users who suffer from late 
pregnancy than control women's group not users of the oral contraceptive pill never. 
oral contraceptive pill In this study  has  shown when compared to the effect of age on the 
concentrations of parameters : showed in table (2). 
Results indicated the presence of a significant decrease (P< 0.05) in the concentration of follicle 
stimulating hormone FSH in the follicular phase of the group of women who have left the use of oral 
contraceptive pill who suffer from late pregnancy and two age groups (20-30) and (31-40) rates (2.678 ± 0.169) , 
(1.449 ± 0.076) when compared with the women control group who did not take their no way to prevent 
pregnancy rates (9.020 ± 0.263) , (6.120 ± 0.324) respectively, whereas when comparing totals for age groups 
themselves in concentration FSH has emerged a significant decrease (P <0.05) was above the second age class 
(31-40) of both groups set women who have left the oral contraceptive pill who suffer from late pregnancy  at a 
rate of (1.449 ± 0.076) when compared with the first age class (20-30) at the rate of (2.678 ± 0.169) . in the 
control group of women who did not take their no way to prevent pregnancy rate of decline was more a rate 
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(6.120 ± 0.324) in the second age class (31-40) when compared with the first age group (20-30) at the rate (9.020 
± 0.263). 
As for the progesterone hormone, the results shown in the study significant increases (P< 0.05) of the 
concentration in the luteal phase of the women  group who have stop the use of oral contraceptive pill who suffer 
from late pregnancy and two age groups (20-30) and (31-40) rates (30.179 ± 0.415) , (42.193 ± 0.443) when 
compared with the women control group who did not take their no way to prevent pregnancy rates (11.062 ± 
0.340) , (23.242 ± 0.733 ) respectively, whereas when comparing totals for age groups themselves in 
concentration progesterone hormone has show a significant increases (P <0.05) was above the second age class 
(31-40) of both groups set women who have left the oral contraceptive pill who suffer from late pregnancy at a 
rate of (42.193 ± 0.443) when compared with the first age class (20-30) at the rate of (30.179 ± 0.415) . in the 
women control group who did not take their no way to prevent pregnancy mean  of height was more a rate 
(23.242 ± 0.733 ) in the second age class (31-40) when compared with the first age group (20-30) at the rate 
(11.062 ± 0.340). 
in the study shown (table 2)  high significant (P< 0.05) of the concentration in the total cholesterol 
(T.Ch) of the group of women who have left the use of oral contraceptive pill who suffer from late pregnancy in 
two age groups (20-30) and (31-40) rates (170.582 ± 0.356) , (181.803 ± 0.273)  compared with the women 
control group who did not take their no way to prevent pregnancy rates (160.780 ± 1.304) , (166.772 ± 0.750 ) 
respectively, when comparing totals for age groups themselves in concentration T.Ch has show a significant 
increases (P <0.05) in the second age class (31-40) of women groups who have left the oral contraceptive pill 
who suffer from late pregnancy at a rate of (181.803 ± 0.273) when compared with the first age class (20-30) at 
the rate of (170.582 ± 0.356) . in the women control group who did not take their no way to prevent pregnancy 
the concentration T.Ch  height but non significant a rate (166.772 ± 0.750 ) in the second age class (31-40) when 
compared with the first age group (20-30) at the rate (160.780 ± 1.304) . 
Results presence of a not significant decrease (P> 0.05) in the concentration  HDL of the women group 
who have left the use of oral contraceptive pill who suffer from late pregnancy and two age groups (20-30) and 
(31-40) rates (40.614 ± 0.285) , (37.702 ± 0.320) when compared with the women control group who did not 
take their no way to prevent pregnancy rates (40.738 ± 0.698) , (38.602 ± 0.757) respectively, when comparing 
totals for age groups themselves in concentration HDL has present at (P <0.05) is  significant  decreases in the 
second age class (31-40) of  women groups  who have left the oral contraceptive pill who suffer from late 
pregnancy at a rate of (37.702 ± 0.320) when compared with the first age class (20-30) a rate (40.614 ± 0.285). 
in the control group of women who did not take their no way to prevent pregnancy rate of decline was more a 
rate (38.602 ± 0.757) in the second age class (31-40) but non significant when compared with the first age group 
(20-30) at the rate (40.738 ± 0.698). 
Table (1): shows the laboratory characteristics of the study population Control Group and women's left 
using oral contraceptive pills who suffer from late pregnancy Group 
women's left using oral contraceptive pills who suffer 
late pregnancy Group 
(Mean ± S.E.) 
N=40 
Control Group  
 
 (Mean ± S.E.) 
N=40 
Hormonal and 
biochemical 
parameters 
 
2.063± 0.134 * 
 
7.570 ± 0.521 * 
 
FSH  
 
36.186± 1.007 * 
 
17.152 ± 2.065 * 
 
Progesterone 
hormone 
 
176.192 ± 0.925 * 
 
± 1.225 * 163.776 
 
T.Ch  
 
39.158 ±  0.314 
 
39.670 ± 0.602  
 
HDL 
*: Means significant difference between the two groups when (P<0.05). 
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Table (2): shows the effect of age on the laboratory characteristics of the study population Control Group 
and women's left using oral contraceptive pills who suffer from late pregnancy Group 
women's left using oral contraceptive pills who 
suffer late pregnancy group 
(Mean ± S.E.) 
N=40 
Control Group  
 
(Mean ± S.E.) 
N=40 
Hormonal and 
biochemical 
parameters 
Year 40-- 31 
N=20 
year  30-20  
N=20 
Year 40-- 31 
N=20 
year  30-20  
N=20 
1.449 ± 0.076 * 
B 
2.678 ± 0.169 *  
a 
6.120 ± 0.324  * 
b 
9.020 ± 0.263 *  
a 
FSH  
42.193 ± 0.443 *  
B 
30.179 ± 0.415 * 
a 
23.242 ± 0.733 *  
b 
11.062 ± 0.340 *  
a 
Progesterone 
hormone 
181.803 ± 0.273 * 
B 
170.582 ± 0.356 * 
 a 
166.772 ± 0.750 *  
a 
160.780 ± 1.304 
* 
a 
T.Ch 
37.702 ± 0.320 
B 
40.614 ± 0.285  
a 
38.602 ± 0.757 
a 
40.738 ± 0.698 
a 
HDL 
*: Means significant difference between the two groups when (P<0.05). 
a.b : Means with different superscript letters  are significantly different (P<0.05). 
 
Discussion 
oral contraceptives pills (OCPs ) afford not only excellent contraception but also a variety of non-contraceptive 
benefits, ranging from regulation and reduction of both menstrual bleeding and treatment of premenstrual 
syndrome, menstrual migraines, acne (Shulman,  2011) . Long-term benefits  include reduced rates of 
endometrial, ovarian, and colorectal cancer (Maguire and Westhoff,  2011), Although it found that there are 
several risk factors associated with OCPs , in One study found the percentage of deaths among women ever 
using OCPs was 12% Compared to women who did not use (OCPs ) (Tsismenakis et al., 2009). through this 
study we found a number of the women have left OCPs for reproduction ; have no pregnancy comparation with 
control group . there is significant difference in (FSH ,Progesterone hormone ,T.ch, HDL). The results indicated 
that significant reduction in the FSH and significant height in the progesterone hormone with positive 
relationship with age . artificial pills hormone works continuously to inhibit the secretion of this hormone GnRH  
(Trussell and James, 2007) , through a competitive link with the receptors and thus inhibits the secretion of 
FSH & LH, and this indicated that the current study show the existence of a significant decrease (P <0.05) in the 
concentration FSH in the follicular phase of women who have left OCPs compared with the control group, the 
results of this study, matching the results obtained ( Huirne and Loenen, 2006) . came the results of the study 
show decreases the concentration of these hormone FSH with age and through the comparison between the age 
groups existence of a significant decrease (P <0.05) was above the second age group. 
The present study showed a large rise significantly in the concentration of the progesterone hormone in 
the women who have OCPs when compared with the control group, this result consistent with the findings of the 
( Zhang et al., 2009) . the reason for the rise is due to the remnants of steroidal hormones of the pills are stored 
in the body and which interfere with the normal functioning of the menstrual hypothalamic pituitary-ovarian 
HPO- axis (Lidegaard et al.  2012), or because of differences in the concentration of hormones (progesterone 
and Estrogen) to the effect of activity of Steroid Hormones Binding Globulin (SHBG) (Manzoli et al., 2012) , 
and that the OCPs contraception is working on the inhibition of ovulation and an increase in the ovarian 
hormones (progesterone and estrogen ), by stimulate the gene in liver cells which increased formation SHBG and 
these in turn are associated with high level of hormone (Shulman,  2011)  . Results of the study also showed that 
with age concentrations of progesterone increased in women who have OCPs compared with a control group, 
and the reason is due to physiological changes associated with offering woman's age .Current steroid 
contraceptive pills still achieve the goal of suppression of pituitary – ovarian activity but the margins for error 
are minimal (Heusden and Fauser, 2002 ) . Most studies show that effect on the endometrial, indicating prevent 
implantation (Meng et al., 2009 ; Meng et al., 2010 ; Palomino et al., 2010 ) . Although clients chose good, 
effective OCP, their use was not always maintained occurrence of pregnancy . Further work is needed to 
understand the reasons for the change of method and plans to improve acceptability and accessibility to more 
effective contraception are being developed to assist women in having more control over their fertility (Graham, 
2013) . Showed the results of the current study, the presence of the effect of age on the studied parameters. This 
is identical to what was in the study (Ozalp et al., 2013) with lack of likelihood of conception pregnant T.Ch 
were significantly different in the women's Group stop using OCPs who suffer late pregnancy group compared to 
the control group of this study. A number of studies into the pill affect the metabolism of fat, so significantly 
changes in the concentrations of T.Ch, (Yesmin et al., 2013) those studies have included conflicting results on 
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the impact of the pill on the concentration of total cholesterol in the blood, some of which have pointed to an 
increase in the concentration of T.Ch  (Santos  et al.,  2008 ), while others pointed to the existence of a 
significant decrease in the concentration of T.Ch (Von-Rooijen et al., 2002) , as other studies have not affected 
total cholesterol using contraception pills explained (Graff-Iversen et al., 2006). The results indicated the 
presence of significant increase (P <0.05) in the concentration of total cholesterol in the serum of women who 
have left the pill compared with the control group, has reason to metabolize hormones pills because 
contraception and stored, the residues can have a continuous effect on metabolism cholesterol even after leaving 
their use and that this effect remains constant even those hormones implemented once and for all, and these 
results are consistent with the findings of the researchers (Emokpae et al., 2010) . may be due the reason for 
increasing the concentration of total cholesterol to the inability of the bile salts dissolved, since progesterone 
hormone works to discourage the conversion of cholesterol into bile acids bile acids process so less than the 
level of bile salts (Stanczyk,  2002) . In both cases, higher results were obtained as a result of T.ch When the 
data were stratified to age , statistically significant increases were seen in the women groups who have stop the 
OCPs who suffer from late pregnancy and control groups for both in (31-40) age, T.ch is high when compared to 
the (20-30) age. Oral contraceptives pill alter the lipid profile through the genomic pathway, in which estrogen 
receptor alterations affect hepatic apolipoprotein upregulation. ( Nelms et al., 2010)  . these results similar to the 
study of (Jones  et al., 2002). also statistically significantly higher Tch in a study ( Okeke et al., 2012 ) . 
Furthermore, statistically significant change in TC and no statistically significant in HDL levels in women on 
OCP was observed in that study. The results of this study also showed a lack of moral differences in the 
concentration of high-density lipoprotein HDL in the serum of women who have left the level of use of the pill 
when compared with the control group. It was reported  (Berenson et al., 2009 ; Druckmann, 2009 ) that the 
use of birth control pills do not cause a significant increase in the concentration of HDL due to the lack of effect 
on HDL receptors, this result is matching the current results of the study concluded that the use of these pills or 
leave it does not affect the concentration of HDL . However, a significant increase was observed in the TC of the 
OCP group and a slight but statistically reduces non-significant of HDL in the OCP group of the present study 
compared control group. In the study  ( Okeke et al., 2012 ), HDL was significantly increased in the OCP 
group ,This is unlike the current study, in contrast Asare .etal. indicated the presence Significant changes in lipid 
profile were observed with HDL (Asare et al., 2014) .  
 
Conclusion: 
use of oral contraceptive Pills linked to change the criteria levels (FSH ,Progesterone hormone ,T.ch, HDL) are 
linked to a strong relationship with age, especially in the group (31-40) 
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